Luteoma of pregnancy masquerading as a granulosa cell tumor.

Granulosa cell tumor Luteoma Pregnant Rare

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 03 02 2023
revised: 08 03 2023
accepted: 11 03 2023
medline: 21 4 2023
pubmed: 21 4 2023
entrez: 21 04 2023
Statut: epublish

Résumé

Pregnancy luteomas are rare, nonmalignant lesions thought to be caused by hormonal changes during pregnancy. Granulosa cell tumor is a rare type of ovarian cancer; 10% occur during pregnancy and typically present with elevated inhibin levels. Herein, we present a case of a pregnant female with a pelvic mass and elevated inhibin B suggestive of a granulosa cell tumor, yet with final pathology consistent with a pregnancy luteoma.

Identifiants

pubmed: 37082520
doi: 10.1016/j.gore.2023.101163
pii: S2352-5789(23)00032-2
pmc: PMC10111934
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101163

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: RM receives research grants under Angle Inc and consulting/speaker fees from Fujirebio Diagnostics Inc. No disclosures from other authors. All fees are outside of submitted work and the authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Obstet Gynecol. 1975 Apr;45(4):407-14
pubmed: 164641
Int J Appl Basic Med Res. 2016 Oct-Dec;6(4):282-283
pubmed: 27857898
Case Rep Obstet Gynecol. 2016;2016:3523760
pubmed: 27660728
Best Pract Res Clin Endocrinol Metab. 2011 Dec;25(6):985-92
pubmed: 22115171
Healthcare (Basel). 2021 Oct 27;9(11):
pubmed: 34828500
Acta Obstet Gynecol Scand. 1986;65(6):583-5
pubmed: 3467532
Integr Cancer Ther. 2008 Sep;7(3):204-15
pubmed: 18815151
Obstet Gynecol Surv. 2010 Sep;65(9):575-82
pubmed: 21144088
Gynecol Endocrinol. 2022 Oct;38(10):885-888
pubmed: 36002954
Mol Cell Endocrinol. 2001 Jun 30;180(1-2):123-30
pubmed: 11451581
Gynecol Oncol. 2006 Feb;100(2):426-9
pubmed: 16256182

Auteurs

Naixin Zhang (N)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Sarah Thappa (S)

Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Janira Navarro Sanchez (J)

Division of Gynecologic Pathology, Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, NY, USA1 Department of Obstetrics and Gynecology, Rochester, NY, USA.

Ashlee Smith (A)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Cici Liu (C)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Cynthia Angel (C)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Brent DuBeshter (B)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Jaclyn Morrison (J)

Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Eva Pressman (E)

Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Richard Moore (R)

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, NY, USA.

Classifications MeSH